|
FY2025
12 months to Oct 3, 2025
|
FY2024
12 months to Sep 27, 2024
|
FY2023
12 months to Sep 29, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Oct 1, 2021
|
|
|---|---|---|---|---|---|
| CASH PROVIDED BY OPERATING ACTIVITIES | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Amortization of deferred financing costs | |||||
| Loss (gain) on sale of productive assets | |||||
| Impairment losses | |||||
| Stock based compensation | |||||
| Provision for credit losses | |||||
| Provision for inventory reserves | |||||
| Deferred income taxes | |||||
| Change in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventories, net | |||||
| Accounts payable and accrued liabilities | |||||
| Other current assets | |||||
| Other non-current assets | |||||
| Other long-term liabilities | |||||
| Other, net | |||||
| Cash provided by operating activities | |||||
| CASH (USED FOR) PROVIDED BY INVESTING ACTIVITIES | |||||
| Payments for purchase of business | |||||
| Purchase of short-term investments | |||||
| Proceeds from maturities of short-term investments | |||||
| Capital expenditures | |||||
| Proceeds from sale of productive assets | |||||
| Cash (used for) provided by investing activities | |||||
| CASH USED FOR FINANCING ACTIVITIES | |||||
| Debt issuance costs paid | |||||
| Common stock transactions | |||||
| Dividends paid | |||||
| Purchases of treasury stock | |||||
| Cash used for financing activities | |||||
| Effect of foreign currency rate changes on cash | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| CASH AND CASH EQUIVALENTS | |||||
| Beginning of period | |||||
| End of period | |||||
| Supplemental Disclosure: | |||||
| Accrued dividends | |||||
| Non-cash treasury activity | |||||
| Cash (received) paid for taxes | |||||
| Cash paid for interest | |||||
Loading...